Fortress Biotech Inc (FBIO)
1.87
+0.03
(+1.63%)
USD |
NASDAQ |
May 24, 16:00
1.87
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Total Liabilities (Quarterly): 168.58M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 168.58M |
December 31, 2023 | 165.94M |
September 30, 2023 | 163.79M |
June 30, 2023 | 196.66M |
March 31, 2023 | 243.74M |
December 31, 2022 | 244.28M |
September 30, 2022 | 222.21M |
June 30, 2022 | 216.25M |
March 31, 2022 | 214.35M |
December 31, 2021 | 170.63M |
September 30, 2021 | 195.36M |
June 30, 2021 | 169.86M |
March 31, 2021 | 146.82M |
December 31, 2020 | 136.41M |
September 30, 2020 | 119.73M |
June 30, 2020 | 151.72M |
March 31, 2020 | 153.47M |
December 31, 2019 | 153.89M |
September 30, 2019 | 146.59M |
June 30, 2019 | 137.44M |
March 31, 2019 | 149.83M |
December 31, 2018 | 121.25M |
September 30, 2018 | 140.28M |
June 30, 2018 | 140.60M |
March 31, 2018 | 157.53M |
Date | Value |
---|---|
December 31, 2017 | 125.45M |
September 30, 2017 | 123.83M |
June 30, 2017 | 99.23M |
March 31, 2017 | 85.59M |
December 31, 2016 | 87.76M |
September 30, 2016 | 70.58M |
June 30, 2016 | 39.85M |
March 31, 2016 | 34.00M |
December 31, 2015 | 34.34M |
September 30, 2015 | 31.94M |
June 30, 2015 | 28.49M |
March 31, 2015 | 30.26M |
December 31, 2014 | 18.80M |
September 30, 2014 | 18.75M |
June 30, 2014 | 18.50M |
March 31, 2014 | 19.41M |
December 31, 2013 | 19.30M |
September 30, 2013 | 19.59M |
June 30, 2013 | 20.22M |
March 31, 2013 | 18.73M |
December 31, 2012 | 18.96M |
September 30, 2012 | 18.96M |
June 30, 2012 | 4.676M |
March 31, 2012 | 4.593M |
December 31, 2011 | 4.243M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
119.73M
Minimum
Sep 2020
244.28M
Maximum
Dec 2022
175.89M
Average
167.26M
Median
Total Liabilities (Quarterly) Benchmarks
Journey Medical Corp | 53.62M |
Avenue Therapeutics Inc | 1.412M |
Checkpoint Therapeutics Inc | 22.22M |
Mustang Bio Inc | 19.54M |
Viking Therapeutics Inc | 33.63M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 164.64M |
Shareholders Equity (Quarterly) | 23.02M |
Debt to Equity Ratio | 2.798 |
Current Ratio | 1.329 |
Net Debt Paydown Yield | 20.08% |